eli lilly clinical trials retatrutide Drug helps people lower blood sugar and lose weight, trial results show Lilly's triple agonist achieves 16.8%

Several herbal species, including Ginkgo biloba, Withania somnifera, Panax ginseng, Curcuma longa, and Camellia sinensis, possess bioactive phytochemicals with antioxidant, anti-inflammatory, anti-amyloidogenic, and neurotrophic activities important to AD therapy (Youn et al., 2021

Tirzepatide is already doing the heavy metabolic lifting

doi: 10.3389/fmolb.2022.889688 26 KoppulaPZhangYZhuangLGanB

It also means cagrilintide could potentially be an option for people who dont respond well to GLP-1-based medications, or who experience side effects that make GLP-1 drugs hard to tolerate

The medication enhances the effectiveness of lifestyle interventions rather than replacing them